JPMorgan Strategist: Financials Could Boom in H2 2026 on Strong Job Growth
A JPMorgan strategist says financial stocks could lead a late-2026 rally if job growth accelerates and broadens beyon...
Market indices provide a snapshot of broad performance and risk. This overview outlines why investors rely on them for benchmarking.
28,391 articlesA JPMorgan strategist says financial stocks could lead a late-2026 rally if job growth accelerates and broadens beyon...
The Trade Desk surged after a large insider purchase by its CEO, lifting the stock among S&P 500 movers as Palantir a...
MemeCore completed its second-stage upgrade, slashing gas fees and enabling smoother on-chain activity. The move spar...
In 2026, MSTR stock has outpaced Bitcoin even as Strategy’s funding stack tests the durability of its preferreds. Inv...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
A famous value investor bets against Caterpillar as the AI infrastructure trend lifts the stock. Market watchers weig...
The weight loss field is heating up, with Novo Nordisk leading the GLP-1 wave and Amgen pursuing a smaller, more sele...
A growing chorus warns that AI-driven efficiency could trigger widespread job cuts. Coinbase’s leadership has amplifi...
Astera Labs’ stock jumped after management laid out a firm timetable for a new switch and signaled growing opportunit...
Goldman Sachs lowers its 12-month oil-price target to align with current market levels as traders weigh the prospects...
As AI hype cools, dividend-focused ETFs draw buyers seeking steadiness. HDV delivers a modest yield with a low fee an...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...